T Cell Hybridomas. T cell hybridomas were produced as previously described by the fusion of Ag/MHC-reactive T cell blasts to the AKR T cell thymoma, BW5147 (15, 16) . The T cell hybridomas DO-11.10 and 7D0-286.2, for example, were produced by priming BALB/c mice in the base of the tail with cOVA. 7 d later, cells from draining lymph nodes were harvested and cultured for 4 d with Ag followed by 3 d incubation with interleukin 2 (IL-2). Live cells were isolated and hybridomas prepared by standard techniques. DO-11.10 was picked and cloned on the basis of its reactivity with cOVA/H-2 d (3).7D0-286.2 was picked and cloned on the basis of its reactivity with a monoclonal anti-Ag/MHC receptor antibody prepared against DO-11.10 (see below). DO-11,10 was a fusion product of female BALB/c mice, 7D0-286.2 was derived from male BALB/c donors.
Monoclonal Antibodies. Monocional antibodies against Ag]MHC receptors on T cell
hybridomas were prepared as previously described (5) . Two were used in the experiments described in this paper. KJ1-26.1, raised against and specific for the Ag/MHC receptor on D0-11.10 (5), and KJ12-98. 15 , raised against and specific for the receptor on 3DT-52.5 (7), a T cell hybridoma which recognizes D d (17) . The anti-Thy-1 monoclonal antibody T24/40.8 (18) was used as a control in ELISA. The following monocional antibodies were used to map I-region specificities of T cell hybridomas, MK-D6, specific bd dk for I-A d'p'q (16) , M5/114, specific for I-A • , I-E ' (19) , 8KP, specific for I-A b'k (amongst many) but not I-A n (20), 14-4-4, specific for I-E d'k (21), MK-S4 specific for I-A S (16), and 11-5.2 specific for I-A k (22) .
Assay for Ag]MHC Recognition.
Receptors for Ag/MHC on T cell hybridomas were assayed by standard methods (16) . Briefly, T cell hybridomas were incubated in microculture wells for 24 h with Ag (usually at 1 mg/ml) and Ag-presenting cells. These last were B cell lymphomas or hybridomas at 10h/well or 4,000 rad-irradiated spleen cells at 106/well. After incubation the supernatants (SN) of these cultures were assayed for IL-2, produced by the T cell hybridomas in response to Ag/MHC. IL-2 concentrations were estimated by serially diluting the SN and measuring their ability to support the growth and survival of the IL-2-dependent T cell line HT-2 (the kind gift of Dr. J. Watson, Auckland, New Zealand). The first dilution in a serial titration that yielded <90% viable HT-2 cells 24 h later was said to contain 1 U of IL-2. 10 U/ml IL-2 was the minimum detectable by this assay.
Karyotyping. T hybridoma cells were prepared for karyotyping by standard methods.
They were incubated with 0.2 tzg/ml colchicine for 30 min at 37°C. After pelleting, they were incubated in 0.075 M potassium chloride for 10 min at 37°C, spun down, and resuspended in fixative (3 parts methanol/1 part glacial acetic acid). After 20 min fixation at room temperature the cells were thoroughly washed in fixative before being dropped from a height onto ethanol-washed, water-covered slides. Banding was done after heating the slides at 95°C for 10 rain by incubating the slides for 10-90 s in tryspin (23), followed by washing and Giemsa staining. Chromosome markers were assigned by the rules of Nesbitt and Francke (24) . ELISA. T hybridoma cells were assayed for the presence of cell surface antigens by ELISA. The procedures used have already been described (25) . Briefly 3 × 10 ~ T hybridoma cells were incubated in 100 #1 of the neat culture SN of an anti-Thy-1 secreting hybridoma (18) , or a 1:250 dilution of ascites produced by the anti-T cell idiotype-secreting B cell hybridomas KJ1-26.1 or KJ12-98.15. The cells were then thoroughly washed before incubation with 1:500 alkaline phosphatase coupled rabbit antimouse immunoglobulin (Sigma Chemical Co.). After thorough washing the cells were incubated at 37°C with p-nitro phenyl phosphate in pH 10.4 buffer (26) . Optical densities (OD) were then read using an ELISA reader (Bio-Tek Instruments, Inc., Burlington, VT).
Immunoprecipitation. Surface membrane proteins on T cell hybridomas were labelled with 12~I using Iodo-gen (Pierce Chemical Go., Rockford, IL) (5). Cell lysates were prepared with NP-40 (5) and immunoprecipitated with monoclonal antibody coupled to Sepharose beads (Pharmacia, Uppsala, Sweden) (27) . Immunoprecipitates were washed thoroughly before solubilization by boiling in electrophoresis loading buffer (28) . Some samples were also reduced by treatment with 5% 2-mercaptoethanol during the boiling. Reduced and unreduced samples were electrophoresed on 10% polyacrylamide gels (PAGE) containing SDS (28) . . We have recently reported (5) the properties of a monoclonal antibody, KJ1-26.1, which appears to bind all or part of the receptor for cOVA/I-A d on the T cell hybridoma D0-11.10. In our original studies this antibody was shown to bind D0-11.10 and cOVA/I-Ad-responsive subclones of this hybridoma, but the antibody did not bind any other T cell hybridoma screened, nor to subclones of DO-11.10 that had lost the ability to respond to cOVA/I-A d. We were curious to find out, however, how frequent the idiotype recognized by KJ1-26.1 was on BALB/c T cells, so for this and other reasons we decided to screen a number of independent T cell hybridomas for reactivity with KJ1-26.1 or KJ12-98, a monoclonal antibody specific for the receptor for D d on the T cell hybridoma 3DT-52.5 (7). Since D0-11.10 was derived from BALB/c T cell blasts specific for cOVA we reasoned that we would be most likely to find a KJ1-26.1 idiotypebearing cell amongst this population. Hybridomas prepared from these T cell blasts were therefore screened. In the vast majority of cases the screening used ELISA to detect KJ1-26.1-binding T cell hybridomas. 307 independent T cell hybridomas prepared in four different fusions were thus tested; some sample results are shown in Table I . All the uncloned T cell hybridomas we tested reacted well with the anti-Thy-1 antibody.
Results

Production of a T Cell Hybridoma That Cross-reacts Idiotypically with
A few hybridomas reacted to a small degree with either KJ1-26.1 or KJ12-08. For example of the hybrids shown in Table I , 7D0-248 had this property. This hybrid, and others like it, were reassayed and showed no binding to either KJ 1-26.1 or KJ12-O8 in subsequent assays. The small positive reading on first assay was probably due to contamination of the hybridoma cells with dead cells or spleen cells from the initial fusion well when they were used in the first assay. A few hybridomas gave very large ELISA readings regardless of the primary antibody added to the assay wells. In Table I , 7D0-185 is an example of this. This hybridoma, and others like it, continued to give high ELISA readings in subsequent assays, i.e., they appeared to bind nonspecifically to either, or both of, the primary or secondary antibody reagents used in the ELISA. Hybrids of this type showed no particularly unusual reactivity with OVA/H-2 d in IL-2 production assays and these reactions were not inhibited or stimulated by KJ1-26.1 or KJ12-98.15. These hybrids were therefore not studied further. One hybridoma, 7D0-286, reacted as strongly with KJ 1-26.1 as with anti-Thy-1 (Table I) . This reaction was consistent in three independent assays. The hybridoma also reacted, less strongly, with KJ12-98. 15 . The reaction with KJ12-98.15 was variable and disappeared after prolonged culture and cloning of the line, moreover it did not appear to be specific since KJ 12-98.15 did not precipitate anything from 7D0-286 (see Fig. 2 ), nor did it interfere with or mimic any reaction of the cell (data not shown).
Because 7D0-286 reacted strongly and consistently with KJ 1-26.1 it was chosen for further examination.
7D0-286 Has a Rare Specificity for Ag/MHC, Shared with DO-11. I0. Preliminary assays showed that 7D0-286 responded well to cOVA/I-A d by producing IL-2, and that this response, like that of D0-11.10, could be inhibited by KJ1-26.1. 7D0-286 was therefore cloned at limiting dilution, all seven clones tested responded to cOVA/I-A d, in every case this response was inhibited by KJ1-26.1. Clone 7D0-286.2 was chosen for further study.
The T cell hybridoma, D0-11.10, has a rare fine specificity for cOVA, as measured by its ability to respond to a variety of bird OVA in the presence of H-2d-bearing antigen-presenting cells, and by its ability to respond to six independent H-2 hapiotypes in the presence or absence of cOVA. In previous experiments (not shown here) we have compared the fine specificities of D0-11.10 and 207 other independent T cell hybridomas, randomly selected from four different fusions of cOVA-specific BALB/c T cell blasts to BW5147, by these criteria. None of the randomly selected hybridomas had the same crossreactivity pattern as D0-11.10. We reasoned that if KJ1-26.1 were specific for an idiotypic determinant on the Ag/MHC receptor of D0-11.10. then 7D0-286.2 should show the same fine specificity for Ag/MHC as D0-11.10. The two T cell hybridomas, and two control cOVA/I-Ad-specific BALB/c-derived T cell hybridomas, 3D0-18.3 and 3D0-54.8 (15) were therefore tested for IL-2 production in the presence of various stimuli. Our results are shown in Tables II-V.  Table II represents the consequences of challenging the four T cell hybridomas with OVA from different birds in the presence of A20-1.11, the H-2d-bearing, Ag-presenting B cell lymphoma (29, 30) . D0-11.10 and 7D0-286.2 responded well to c and jfOVA and weakly, in this experiment, to tOVA. They did not respond to any other bird OVA tested. The two control T cell hybridomas, 3D0-18.3 and 3D0-54.8, had different reactivity patterns. 3D0-18.3 responded well to c and jfOVA, and also to ph and qOVA; 3D0-54.8 responded strongly to c, if, and qOVA. Thus, D0-11.10 and 7D0-286.2 share fine specificity for bird OVA and their cross-reactivity pattern is not common to many BALB/c anticOVA T cells. Table III demonstrates that D0-11.10 and 7D0-286.2 responded to cOVA/ H-2 d but not to H-2 r, H-2 q, H-2 t2 or Mls a, with or without OVA. Both hybridomas responded weakly to H-2 b. These responses were markedly increased by the addition of cOVA. Neither of the two control T cell hybridomas shown, not any of 205 other T cell hybridomas (not shown) had the same reaction pattern in this assay as DO-11.10 and 7D0-286. 2 To do the experiments shown in Table IV we tested the responses of D0-11.10 or 7D0-286.2 to cOVA/H-2 b and cOVA/H-2 a in the presence of various monoclonal antibodies. These antibodies were all present at concentrations known to inhibit effectively reactions for which their specificities would be appropriate. Monocional antibody culture SN were present at a 1:10 dilution, ascites at 1:100 or 1:250. The responses of D0-11.10 and 7D0-286. We have recently shown that D0-11.10 and 3D0-54.8 recognize a tryptic peptide (amino acids 316-342) of cOVA, when presented by I-Ad-bearing cells, even if these Ag-presenting cells have been fixed with glutaraldehyde (reference 15, and unpublished observations). The fixed cells were, however, unable to present intact cOVA to these hybridomas presumably because they could no longer "process" the intact protein. The tryptic peptide has recently been synthesized for us (with the addition of a C terminal tyrosine) by Dr. Gary Matsueda, Massachusetts General Hospital, Boston, MA. The synthetic peptide is called p143. D0-11.10 and 3D0-54.8 respond well to p143, presented on live or fixed I-Ad-bearing cells. 7D0-286.2 was therefore tested for the same activity. As shown in Table V fixed A20-1.11 cells presented p143 to D0-11.10, 3D0-54.8, and 7D0-286.2, but not to 3D0-18.3, which is known to recognize a different peptide derivative of cOVA (15) . Thus, D0-11.10 and 7D0-286.2 recognize the same peptide fragment of cOVA. . The experiments described above show that the Ag and H-2 specificities of 7 D0-286.2 and DO-11.10 are both rare, and indistinguishable. Since D0-11.10 is almost always being cultured by one member or another of our laboratory it was possible that 7D0-286.2 was not an independent T cell hybridoma, but simply DO-11.10 that had accidently contaminated the 7D0 fusion plates. One cell would have been sufficient to give us the results we have reported so far. Even though every precaution was taken to ensure that this would not occur, and even though contamination of this type has not previously been observed in our laboratories, we felt we should demonstrate directly that this had not happened.
7D0-286.2 Is Not a Reisolate of
It is our experience that T cell hybridomas, even though they are products of the fusion of a normal mouse T cell (containing 40 chromosomes) to the same tumor cell parent, BW5147, contain variable numbers of normal and abnormal mouse chromosomes (31). Most of the abnormal chromosomes seem to be derived from BW5147, which contains a number of characteristic chromosomes of this type (32). Others appear to form soon after the fusion of the normal T cell parent and BW5147, by fusion or rearrangement of chromosomes in the hybrid. The creation of the abnormal chromosomes seems to be an early rather than a late event in the life history of hybridomas, since once the hybridoma has been cloned marker chromosomes remain constant. Subcloning the hybridoma may lead to the production of subclones that have lost particular abnormal chromosomes, but no new ones appear (unpublished observations). D0-11.10 was derived from a female BALB/c mouse; BW5147 does not contain a Y chromosome; the normal T cell parent of 7D0-286.2, on the other hand, was male. We therefore karyotyped D0-11.10 and 7D0-286.2 with the hope that the presence or absence of a Y chromosome, as well as clone-specific distribution of chromosomes would allow us to distinguish unequivocally the two hybridomas. Sample spreads are shown in Fig. 1 .
Even in these cloned T cell hybridomas, chromosome numbers did vary somewhat from spread to spread. Nevertheless, D0-11.10 and 7D0-286.2 did differ chracteristically. For example all spreads of 7D0-286.2 contained a Y chromosome (in Fig. 1 an arrow points to this chromosome); this was never observed in a karyotype of D0-11.10. 7D0-286.2 cells consistently contained 2 chromosomes 4, 2 or 3 chromosomes 12, and one or zero chromosomes 18. D0-11.10 spreads always contained one normal chromosome 4, 4 normal chromosomes 12, and 2 or 3 chromosomes 18. These data demonstrate unequivocally that 7D0.286.2 is not a reisolate of D0-11.10.
Immunoprecipitation of 7D0-286.2. D0-11.10 and 7D0-286.2 were surface labeled with 125I and lysed, and immunoprecipitates prepared with either KJ1-26.1 These fine specificities are relatively rare amongst T cell hybrids prepared from BALB/c T cell blasts specific for cOVA, in fact others with this pattern have not been seen amongst 207 tested. In addition none other of 397 independent T cell hybridomas tested reacted specifically with the anti-receptor antibody KJ1-26.1.
From these results we would like to draw several conclusions. First, and most importantly, we feel that these results show unequivocally that KJ1-26.1 binds to all or part of the receptor for cOVA/I-A d on D0-11.10 and 7D0-286.2, since the presence of the idiotype predicted exactly the specificity of the T cells. Prior to this discovery the evidence that antibodies of this type reacted with Ag/MHC receptors on T ceils rested on the facts that they are clone-specific, that they block responses against and binding to Ag/MHC and that they do not bind to subclones of T cell hybridomas thought to have lost the ability to put Ag/MHC receptors on their surfaces (1) (2) (3) (4) (5) (6) (7) (8) 14) . Of course, in the case of the long-soughtfor T cell Ag/MHC receptors, the more evidence that can be mustered to support the candidacy of a particular molecule the better; a demonstration that the suspect binds to Ag/MHC, for example, would be most welcome. Unfortunately, our preliminary attempts to demonstrate this have been unsuccessful, perhaps because of obligatory requirements for other molecules, LFA-1, L3T4, or Lyt-2 (9-13). In lieu of such data we feel that our demonstration that idiotype determines specificity is a useful addition to the literature on this subject.
The fact that reaction with KJ1-26.1 predicted the fine specificity of 7D0-286.2 both for Ag and MHC places certain restrictions on models for how Ag/ MHC recognition occurs. Certainly, it is compatible with a single receptor model (33), as is the fact that KJ1-26.1, and other antibodies like it, have been shown to precipitate 80-90-kdalton disulphide-bonded heterodimers from cell surfaces which, on reduction yield two polypeptide chains, both of variable sequence of mol wt 39-47 kdaltons (4) (5) (6) (7) 14) . Moreover, recently a number of other publications have also suggested that a single receptor model may describe the structure of the T cell receptor and its ligands (16, 34, 35) . To allow the data in this paper to be compatible with two receptor models (36), we have to postulate that the structure of the Ag and MHC receptors are not independent: one might be derived from the other (37), or they might be constructed from different parts of the same polypeptide chains (38). Constraints of this type have, of course, already been imposed on two receptor theories by the existence of antigenspecific, MHC-iinked Ir genes.
A second point worth noting is that the idiotype recognized by KJ 1-26.1 occurs relatively infrequently. Only 1 of about 400 T cell hybridomas was found to bear it, even when the hybridomas were derived from T cells with the same gross Ag/MHC specificity as the original target of KJ1-26.1. Although it is impossible to generalize from this single example, the result is consistent with the idea that the variability of T cell Ag/MHC receptors is relatively large, at least as large as that of B cells.
Summary
In order to prove that a monoclonal antibody, KJ1-26.1, reacted with the idiotypic portion of the receptor for antigen plus major histocompatibility complex product (Ag/MHC) on the T cell hybridoma D0-11.10,397 independent T cell hybridomas prepared from BALB/c T cells primed with ovalbumin were screened by ELISA for reactivity with the antibody. Of these T cell hybridomas one, 7D0-286, and a subclone of this hybridoma, 7D0-286.2, reacted strongly and consistently with KJ 1-26.1. Further analysis revealed that KJ 1-26.1 blocked the reaction of 7D0-286 with Ag/MHC, and that 7D0-286 had the same fine specificity both for Ag and MHC as D0-11.10. None of 207 other BALB/c T cell hybridomas specific for ovalbumin shared these fine specificity patterns.
Thus, reaction with KJ1-26.1 defined the specificity of a T cell hybridoma both for Ag and MHC, suggesting that KJ1-26.1 reacted with the receptors for Ag/MHC on the T cells in question.
KJ1-26.1 precipitated an 85-kdalton molecule from 7D0-286.2 that on reduction ran as a diffuse spot of ~43 kdaitons. A similar molecule was precipitated from D0-11.10.
